Additional investigations implicating the RhoA/ROCK pathway in the pathogenesis of hypertension, coronary vasospasm, stroke, atherosclerosis, heart failure, and diabetes indicate its potential role as an important therapeutic target. Here, RHOA is linked to diabetes mellitus.